Sign in
4/A

Changes in Ownership

Edgewise Therapeutics, Inc. Filed Acc 0001705477-26-000002

Options or other derivatives

  • Chief Financial Officer acquired 48,750 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Nofi Michael · Chief Financial Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-08-12 Grant or award : show line 1 in the form Stock Option (Right to Buy) +48,750 48,750 D
Loading xslF345X06/primarydocument.xml…